Home › Research › Risk factors
Residential Neighborhood Disadvantage and Amyloid Positivity: Findings from IDEAS
Charles Windon, Elena Tsoy, Jennifer Livaudais‐Toman, Lucy Hanna, Constantine G. Gatsonis, Marı́a C. Carrillo, Charles S. Apgar, Peggye Dilworth‐Anderson et al.. Alzheimer s & Dementia, 2024-12-01
Topic: Amyloid, tau and blood-test diagnosis
Plain-language summary
Abstract Background Residence in a disadvantaged neighborhood (e.g., high poverty rate, poor housing, etc.) is associated with greater dementia risk and possibly greater postmortem Alzheimer’s pathology. It remains unknown if neighborhood disadvantage is associated with in vivo beta‐amyloid positron emission tomography (PET) for Alzheimer’s. Results Among 13,961 cognitively impaired participants, 61.6% were amyloid positive, 56.5% had MCI, and 50.4% were female (Table 1). Greater ADI was associated with lower odds of amyloid positivity (aOR 0.61, 95% CI 0.51‐0.73, p<.001 for ADI 10 vs ADI 2 and aOR 0.87, 0.76‐1.00, p .051 for ADI 2 vs. Latino (aOR 0.62, 0.48‐0.80, p<.001), Black (aOR 0.58, 0.48‐0.72, p<.001), and Asian (aOR 0.42, 0.31‐0.58, p<.001) identity was associated with lower odds of amyloid positivity along with multiple comorbidities (Table 2). Conclusion We observed a relationship between residence in a more disadvantaged neighborhood (higher ADI) and lower rates of amyloid positivity.
What this study adds
Evidence grade: Low
In this study of cognitively impaired participants, living in a more disadvantaged neighborhood was linked to lower odds of having amyloid plaques on a PET scan. Reported effect size: 61.6%; 56.5%; 50.4%.
Taken from this record’s own fields, not from reading the paper. The grade is assigned from the abstract’s wording; what that means.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
Windon, C., Tsoy, E., Livaudais‐Toman, J., Hanna, L., Gatsonis, C. G., Carrillo, M. C., et al. (2024). Residential Neighborhood Disadvantage and Amyloid Positivity: Findings from IDEAS. Alzheimer s & Dementia. https://doi.org/10.1002/alz.094017
Vancouver
Windon C, Tsoy E, Livaudais‐Toman J, Hanna L, Gatsonis CG, Carrillo MC, et al. Residential Neighborhood Disadvantage and Amyloid Positivity: Findings from IDEAS. Alzheimer s & Dementia. 2024. doi:10.1002/alz.094017.
BibTeX
@article{windon2024-23bc1148,
author = {Windon, Charles and Tsoy, Elena and Livaudais‐Toman, Jennifer and Hanna, Lucy and Gatsonis, Constantine G. and Carrillo, Marı́a C. and Apgar, Charles S. and Dilworth‐Anderson, Peggye and others},
title = {{Residential Neighborhood Disadvantage and Amyloid Positivity: Findings from IDEAS}},
journal = {Alzheimer s \& Dementia},
year = {2024},
doi = {10.1002/alz.094017},
url = {https://doi.org/10.1002/alz.094017}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. The record's author list ends in “et al.”, so not every author is named. Check the citation against the original before you use it.
Key findings
- Abstract Background Residence in a disadvantaged neighborhood (e.g., high poverty rate, poor housing, etc.) is associated with greater dementia risk and possibly greater postmortem Alzheimer’s pathology.
- It remains unknown if neighborhood disadvantage is associated with in vivo beta‐amyloid positron emission tomography (PET) for Alzheimer’s.
- Results Among 13,961 cognitively impaired participants, 61.6% were amyloid positive, 56.5% had MCI, and 50.4% were female (Table 1).
- Greater ADI was associated with lower odds of amyloid positivity (aOR 0.61, 95% CI 0.51‐0.73, p<.001 for ADI 10 vs ADI 2 and aOR 0.87, 0.76‐1.00, p .051 for ADI 2 vs.
- Latino (aOR 0.62, 0.48‐0.80, p<.001), Black (aOR 0.58, 0.48‐0.72, p<.001), and Asian (aOR 0.42, 0.31‐0.58, p<.001) identity was associated with lower odds of amyloid positivity along with multiple comorbidities (Table 2).
Why it matters
In this study of cognitively impaired participants, living in a more disadvantaged neighborhood was linked to lower odds of having amyloid plaques on a PET scan. It does not test any treatment or prevention for Alzheimer's disease, and the reasons for this link are not known.
New to this subject? Start with our plain-English guide: Risk factors, ranked →
Study details
- Effect size61.6%; 56.5%; 50.4%
- Evidence strengthLow
How this study scored 37/100
Published in a peer-reviewed journal. Scored zero for study design, sample size, studied in people and randomized / blinded because the record does not state it.
| Component | Points | Why |
|---|---|---|
| Journal tier | 7 / 10 | Tier 3 — peer-reviewed journal (Alzheimer s & Dementia) |
| Journal's citation record | 2 / 4 | Alzheimer s & Dementia: journal h-index 228 (OpenAlex, 2026-10-29) |
| Study design | 0 / 12 | No study design recorded — scores zero, not guessed (not stated in the record — scored 0) |
| Strength of evidence | 1 / 5 | Rated “low” in our summary |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 4 / 5 | 2024 — within 3 year(s) of the newest study here |
| Sample size | 0 / 4 | Participant count not stated — scores zero (not stated in the record — scored 0) |
| Effect reported | 2 / 3 | Effect reported as a number, without an interval or test |
| Studied in people | 0 / 3 | Not stated whether this was studied in people — scores zero (not stated in the record — scored 0) |
| Randomized / blinded | 0 / 2 | No randomization or blinding stated — scores zero (not stated in the record — scored 0) |
| Times cited | 0 / 7 | Cited 0 times (OpenAlex, 2026-10-10) |
| Citations per year | 0 / 5 | 0.0 citations a year over 4 year(s) since 2024 |
| Impact for its field and year | 0 / 6 | Cited 0.0× the average for papers of its field and year (OpenAlex FWCI) |
| Cited by studies here | 0 / 6 | No other study in this library cites it |
| Still being cited | 0 / 4 | Cited 0 times in 2024–2026 (2026 still in progress; OpenAlex) |
| Senior author's track record | 4 / 4 | Last-listed author Gil D. Rabinovici: h-index 116 (OpenAlex, whole career) |
| Institution's track record | 2 / 3 | University of California, San Francisco: institution h-index 1,915 (OpenAlex) |
| Multicenter collaboration | 2 / 3 | OpenAlex lists 8 institution(s) in 1 country |
| Indexed in PubMed | 1 / 2 | Not in PubMed, but has a DOI |
| Free to read | 2 / 2 | Free to read |
| Total | 37 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).
Related
Studies in the library that share something with this one. The line above each title says what.
Related studies in Risk factors from nearby years
Also tagged “precursor”
1,337 studies in the library carry the topic tag “precursor”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 1,337 tagged studies.